Skip to main content
AKBA
NASDAQ Life Sciences

Akebia Secures New Vafseo Patent, Extends Key IP to 2032

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.917
Mkt Cap
$246.798M
52W Low
$0.875
52W High
$4.079
52W Position info
4.8% above low
Off High info
78% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AKBA is trading near its 52-week low of $0.875 (4.8% above the low).

Summary

Akebia Therapeutics announced a new patent for its key drug Vafseo (vadadustat) has been granted, and a composition of matter patent is eligible for a five-year extension, pushing its expiration to mid-2032. This significantly strengthens the intellectual property for Vafseo, which is the company's primary growth product and the only oral HIF-PH inhibitor in the U.S. The extended exclusivity is crucial for Akebia, especially after recent Q1 results showed a net loss and generic competition impacted their Auryxia drug. This development provides a longer revenue runway and reduces the risk of early generic competition for their most important asset.

At the time of this announcement, AKBA was trading at $0.92 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $246.8M. The 52-week trading range was $0.88 to $4.08. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

AKBA - Latest Insights

AKBA
Nov 16, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.4739
Real-time Price: $0.40775 info
Change: -$0.06615 (-14%) info
Market Cap: $113.217M info
AKBA
Nov 05, 2026, 7:37 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.5199
Real-time Price: $0.40775 info
Change: -$0.11215 (-22%) info
Market Cap: $113.217M info
AKBA
Nov 05, 2026, 7:10 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.69337
Real-time Price: $0.40775 info
Change: -$0.28562 (-41%) info
Market Cap: $113.217M info
AKBA
Nov 05, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.69337
Real-time Price: $0.40775 info
Change: -$0.28562 (-41%) info
Market Cap: $113.217M info
AKBA
Oct 26, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.5765
Real-time Price: $0.40775 info
Change: -$0.16875 (-29%) info
Market Cap: $113.217M info